(FBZ) First Trust Brazil AlphaDEX - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US33737J1337 • Latin America Stock

FBZ: Equities, Brazilian, Alpha, Emerging Markets, ETF

The First Trust Brazil AlphaDEX® Fund (NASDAQ:FBZ) is an exchange-traded fund (ETF) designed to provide exposure to Brazilian equities by tracking the NASDAQ Brazil Index through the AlphaDEX® selection methodology. The fund seeks to outperform traditional indices by selecting stocks with the potential for positive alpha, or risk-adjusted returns. It typically invests at least 90% of its net assets in securities from the NASDAQ Brazil Index, leveraging a rules-based approach to identify companies with strong fundamental and operational metrics.

The AlphaDEX® methodology employs a proprietary scoring system to rank stocks in the base index based on factors such as price momentum, revenue, and operating efficiency. This process aims to enhance returns by weighting securities based on their alpha-generating potential rather than market capitalization. The fund is part of First Trusts lineup of AlphaDEX® ETFs, which focus on specific regions or sectors to deliver targeted exposure.

Based on the provided data, the fund currently has an average 20-day trading volume of 1,121 shares, with a last price of $9.94. The short-term moving average (SMA 20) stands at $10.13, slightly above the last price, while the SMA 50 is at $9.90, indicating a potential near-term support level. The SMA 200 at $10.24 suggests a longer-term resistance level. The Average True Range (ATR) of 0.21 reflects low volatility in recent trading activity.

With assets under management (AUM) of $5.36 million, the fund is relatively small compared to other ETFs in its category. This smaller size may result in higher risk due to less liquidity but could also allow for more agile performance in response to market movements.

Over the next three months, the fund is expected to trade within a narrow range, bounded by the SMA 50 ($9.90) and SMA 200 ($10.24), based on the provided. The low ATR of 0.21 suggests that price fluctuations will likely remain subdued. If the fund breaks above the SMA 20 ($10.13), it could signal a bullish trend, while a drop below the SMA 50 ($9.90) may indicate a bearish reversal. The indicates that the funds small AUM could amplify volatility, making it sensitive to broader market movements in Brazilian equities.

Additional Sources for FBZ ETF

FBZ ETF Overview

Market Cap in USD 6m
Category Latin America Stock
TER 0.80%
IPO / Inception 2011-04-18

FBZ ETF Ratings

Growth Rating 28.0
Fundamental -
Dividend Rating 46.4
Rel. Strength -9.68
Analysts -
Fair Price Momentum 10.84 USD
Fair Price DCF -

FBZ Dividends

Dividend Yield 12m 3.93%
Yield on Cost 5y 6.60%
Annual Growth 5y 4.47%
Payout Consistency 73.1%

FBZ Growth Ratios

Growth Correlation 3m 55.5%
Growth Correlation 12m -55.3%
Growth Correlation 5y 54.3%
CAGR 5y 11.54%
CAGR/Max DD 5y 0.36
Sharpe Ratio 12m 0.38
Alpha -5.66
Beta 0.420
Volatility 30.74%
Current Volume 1.8k
Average Volume 20d 2.1k
What is the price of FBZ stocks?
As of May 01, 2025, the stock is trading at USD 11.00 with a total of 1,786 shares traded.
Over the past week, the price has changed by +2.66%, over one month by +8.33%, over three months by +13.02% and over the past year by +1.77%.
Is First Trust Brazil AlphaDEX a good stock to buy?
Neither. Based on ValueRay Analyses, First Trust Brazil AlphaDEX is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 27.95 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FBZ as of May 2025 is 10.84. This means that FBZ is currently overvalued and has a potential downside of -1.45%.
Is FBZ a buy, sell or hold?
First Trust Brazil AlphaDEX has no consensus analysts rating.
What are the forecast for FBZ stock price target?
According to ValueRays Forecast Model, FBZ First Trust Brazil AlphaDEX will be worth about 12 in May 2026. The stock is currently trading at 11.00. This means that the stock has a potential upside of +8.82%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 12 8.8%